Avalo Therapeutics (AVTX) Invested Capital (2014 - 2023)
Avalo Therapeutics (AVTX) recorded Invested Capital of $7.3 million in Q4 2023, down 14.1% from $8.5 million a year earlier and down 50.3% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Invested Capital (2014 - 2023) Analysis & Trends
Starting with Q4 2014, Avalo Therapeutics' Invested Capital history includes 27 quarters.
- Annual Invested Capital has a five-year compound annual growth rate of -27.4% (FY2018 to FY2023).
- Across earlier years, Invested Capital came in at $8.5 million in FY2022 (-84.8%), $55.92 million in FY2021 (+127.6%) and $24.56 million in FY2020.
- Quarterly Invested Capital has ranged from $7.15 million in Q2 2023 to $55.92 million in Q4 2021 over the past five years.
- On a year-over-year basis, Invested Capital has declined for three consecutive quarters, with an average decline of 39.2% over the last four quarters.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 127.6% in Q4 2021, against a decline of 84.8% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.7 million (Q3 2023), $7.15 million (Q2 2023) and $13.5 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Avalo Therapeutics | 651.85 Mn | 651.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 7.30 Mn |
| Sep 30, 2023 | 14.70 Mn |
| Jun 30, 2023 | 7.15 Mn |
| Mar 31, 2023 | 13.50 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 17.04 Mn |
| Jun 30, 2022 | 12.76 Mn |
| Dec 31, 2021 | 55.92 Mn |
| Dec 31, 2020 | 24.56 Mn |
| Sep 30, 2019 | 33.53 Mn |
| Jun 30, 2019 | 33.03 Mn |
| Mar 31, 2019 | 38.47 Mn |
| Dec 31, 2018 | 36.29 Mn |
| Sep 30, 2018 | 34.91 Mn |
| Jun 30, 2018 | 34.65 Mn |
| Mar 31, 2018 | 39.96 Mn |
| Dec 31, 2017 | 27.86 Mn |
| Sep 30, 2017 | 22.12 Mn |
| Jun 30, 2017 | 3.74 Mn |
| Mar 31, 2017 | 1.07 Mn |
API Access
Avalo Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();